1 Disorders of prolactin and growth hormone secretion

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Clinics in Endocrinology and Metabolism

• Publication date

  1985-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0300-595X(85)80063-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Pituitary Gland

  2011cited by this paper
• 6 Growth hormone neurosecretory dysfunction

  1986cited by this paper
• Acceleration of growth in two children treated with human growth hormone-releasing factor.

  1985cited by this paper
• Isolated growth hormone deficiency: immunocytochemistry.

  1984cited by this paper
• A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

  1984cited by this paper
• 7 Somatomedin activity in disorders of nutrition and metabolism

  1984cited by this paper
• Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients.

  1984cited by this paper
• Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.

  1984cited by this paper
• Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

  1984cited by this paper
• Hyperprolactinemia in Cushing's disease and Nelson's syndrome.

  1984cited by this paper
• Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia.

  1984cited by this paper
• Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.

  1984cited by this paper
• Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.

  1984cited by this paper
• Growth hormone neurosecretory dysfunction. A treatable cause of short stature.

  1984cited by this paper
• Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature.

  1984cited by this paper
• Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.

  1984cited by this paper
• Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.

  1984cited by this paper
• Prospective clinical trial of human growth hormone in short children without growth hormone deficiency.

  1984cited by this paper
• Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.

  1984cited by this paper
• 6 Factors controlling blood concentration of somatomedin C

  1984cited by this paper
• Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.

  1984cited by this paper
• Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly.

  1984cited by this paper
• Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I.

  1983cited by this paper
• GROWTH HORMONE SECRETION AND PLASMA SOMATOMEDIN‐C IN PRIMARY HYPOTHYROIDISM

  1983cited by this paper
• A preliminary study of the effect of estrogen dose on growth in Turner's syndrome.

  1983cited by this paper
• Pathophysiology of acromegaly.

  1983cited by this paper
• "Claudication" of the sciatic nerve.

  1983cited by this paper
• Growth hormone response to thyrotropin-releasing hormone and oral glucose-loading tests in tall children and adolescents.

  1983cited by this paper
• Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men.

  1983cited by this paper
• Effects of a growth hormone releasing factor in man.

  1983cited by this paper
• A unique growth factor in patients with acromegaloidism.

  1983cited by this paper
• Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.

  1983cited by this paper
• Use of a two-site immunoradiometric assay for growth hormone (GH) in identifying children with GH-dependent growth failure.

  1983cited by this paper
• Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF (1-44) ) in acromegaly and hypopituitarism.

  1983cited by this paper
• Ulcerative enteritis.

  1983cited by this paper
• CRITICAL STUDY OF THE GROWTH HORMONE RESPONSE TO DYNAMIC TESTS AND THE INSULIN GROWTH FACTOR ASSAY IN ACROMEGALY AFTER MICROSURGERY

  1983cited by this paper
• Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.

  1983cited by this paper
• Human pancreatic growth hormone-releasing factor-40 (hpGRF-40) allows stimulation of GH release by TRH.

  1983cited by this paper
• Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man.

  1983cited by this paper
• Growth hormone treatment for short stature.

  1983cited by this paper
• Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

  1982cited by this paper
• Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics.

  1982cited by this paper
• Nonspecific growth hormone responses to thyrotropin-releasing hormone in insulin-dependent diabetes: sex- and age-related pituitary responsiveness.

  1982cited by this paper
• The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children.

  1982cited by this paper
• The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.

  1982cited by this paper
• Genetic analysis of familial isolated growth hormone deficiency type I.

  1982cited by this paper
• Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix.

  1982cited by this paper
• Growth hormone--dependent growth failure.

  1982cited by this paper
• Insulin-like growth factors in the fed and fasted states.

  1982cited by this paper
• CHANGES IN CIRCULATING SOMATOMEDIN‐C LEVELS IN BROMOCRIPTINE‐TREATED ACROMEGALY

  1982cited by this paper
• Prolactin secretion and dopamine receptors of the MtTW15 transplantable pituitary tumour.

  1982cited by this paper
• Hypothalamic serotoninergic stimulation of thyrotropin secretion and related brain-hormone and drug interactions in the rat.

  1982cited by this paper
• Daytime pulsatile growth hormone secretion during childhood and adolescence.

  1982cited by this paper
• The decrease in hypothalamic dopamine secretion induced by suckling: comparison of voltammetric and radioisotopic methods of measurement.

  1982cited by this paper
• Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.

  1982cited by this paper
• The Acromegaly Syndrome

  1982cited by this paper
• Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.

  1981cited by this paper
• Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.

  1981cited by this paper
• Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series.

  1981cited by this paper
• Children with normal-variant short stature: treatment with human growth hormone for six months.

  1981cited by this paper
• The 7315a pituitary tumor is refractory to dopaminergic inhibition of prolactin release but contains dopamine receptors.

  1981cited by this paper
• Role of estrogen in the dopaminergic control of prolactin secretion.

  1981cited by this paper
• Plasma Somatomedin-C as a screening test for growth hormone deficiency in children and adolescents

  1981cited by this paper
• Hormonal control of growth in the infant rat.

  1981cited by this paper
• [Total venous autograft of the superior longitudinal sinus. Experimental study in the dog (author's transl)].

  1981cited by this paper
• Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response.

  1981cited by this paper
• Reduction of plasma immunoreactive somatomedin C during fasting in humans.

  1981cited by this paper
• Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.

  1981cited by this paper
• Defective suppression of growth hormone after oral glucose loading in adolescence.

  1980cited by this paper
• Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study.

  1980cited by this paper
• Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure.

  1980cited by this paper
• Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.

  1980cited by this paper
• Bromocriptine in the medical management of acromegaly.

  1980cited by this paper
• A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine.

  1980cited by this paper
• Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.

  1980cited by this paper
• Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.

  1980cited by this paper
• Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine.

  1980cited by this paper
• [3H]Spiperone binding to human anterior pituitaries and pituitary adenomas secreting prolactin, growth hormone, and adrenocorticotropic hormone.

  1980cited by this paper
• Effects of altered thyroid function on plasma prolactin clearance.

  1980cited by this paper
• Prolactin-secreting pituitary adenomas: transsphenoidal microsurgical treatment.

  1980cited by this paper
• X-linked hypogammaglobulinemia and isolated growth hormone deficiency.

  1980cited by this paper
• Alteration of Cartilage Glycosaminoglycan Protein Acceptor by Somatomedin and Cortisol

  1979cited by this paper
• Prolactin-secreting tumors and hypogonadism in men.

  1979cited by this paper
• Pituitary adenomas. Clinico-morphologic correlations.

  1979cited by this paper
• Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas

  1979cited by this paper
• Evaluation of acromegaly by radioimmunoassay of somatomedin-C.

  1979cited by this paper
• The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.

  1979cited by this paper
• EVALUATION OF THE RESULTS OF TRANS‐SPHENOIDAL SURGERY IN ACROMEGALY BY ASSESSMENT OF THE GROWTH HORMONE RESPONSE TO THYROTROPHIN‐RELEASING HORMONE

  1978cited by this paper
• Pituitary function and growth hormone dynamics in acromegaloidism.

  1978cited by this paper
• Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.

  1978cited by this paper
• Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours.

  1977cited by this paper
• Galactorrhea-amenorrhea syndrome: diagnosis and therapy.

  1977cited by this paper
• Effects of prolactin (PRL) on pituitary and testicular function in mice with hereditary PRL deficiency.

  1977cited by this paper
• INCREASING GROWTH WITH RAISED CIRCULATING SOMATOMEDIN BUT NORMAL IMMUNOASSAYABLE GROWTH HORMONE

  1977cited by this paper
• Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

  1977cited by this paper
• Aetiology of idiopathic growth hormone deficiency in England and Wales.

  1977cited by this paper
• Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

  1977cited by this paper
• Growth hormone deficiency after treatment of acute leukaemia in children.

  1976cited by this paper
• Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.

  1976cited by this paper
• Effects of oral contraceptive steroids on pituitary prolactin secretion.

  1976cited by this paper

• Effect of a 6-week program of physical therapy on the risk of falls in women with type II diabetes

  2014cites this paper
• CHAPTER 50 – Pituitary

  2009cites this paper
• PL04 From ancient Greece to modern Athens: 3000 years of doping in competition horses

  2006cites this paper
• Severe hypersomnolence after pituitary/hypothalamic surgery in adolescents: clinical characteristics and potential mechanisms.

  2002cites this paper
• The pathology of pituitary tumors.

  1999cites this paper
• Ibuprofen fails to increase plasma growth hormone levels in humans.

  1993cites this paper
• High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma

  1993cites this paper
• Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.

  1992cites this paper
• Comparison of Overnight Serum Human Growth Hormone (hGH) Secretory Profiles Measured by Three Different Methods

  1991cites this paper
• Indomethacin increases plasma growth hormone levels in man.

  1990cites this paper
• Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.

  1989cites this paper
• Suprasellar Germinoma - Occult Presentation with Hypothalamic Failure 18 Months Before Diagnosis

  1989cites this paper
• Therapeutic Applications of Bromocriptine in Endocrine and Neurological Diseases

  1988cites this paper
• Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications

  1988cites this paper
• Klinik und Differentialdiagnose der Hyperprolaktinämiesyndrome bei Männern

  1988cites this paper
• Arginine induced growth hormone (hGH) response and paradoxical hGH secretion stimulated by TRH in diabetes mellitus

  1987cites this paper
• Low-dose oral clonidine: effective growth hormone releasing agent in children but not in adolescents.

  1987cites this paper
• The Diagnosis of Acromegaly

  1987cites this paper
• Psychoneuroendocrine Testing: Strategy and Attitude

  1987cites this paper
• TALL STATURE: A CLINICAL, ENDOCRINOLOGICAL AND RADIOLOGICAL STUDY

  1986cites this paper
• Evaluation of a commercial immunoenzymometric assay for human prolactin.

  1986cites this paper
• 6 Growth hormone neurosecretory dysfunction

  1986cites this paper